Harrow Health, Inc. 11.875% Senior Notes due 2027

Harrow Health, Inc. focuses on the creation, production, and marketing of cutting-edge pharmaceutical solutions. Its business activities are primarily organized into two distinct divisions: Pharmaceutical Compounding and Pharmaceutical Drug Development. Specifically, the Pharmaceutical Compounding segment oversees the operations of the ImprimisRx enterprise. The company was established in January 2006 by Mark L. Baum and Robert J. Kammer, and its main corporate office is located in Nashville, Tennessee.